Uterine Cancer
Oncology·MeSH: Ovarian Neoplasms
Prevalence
50.1 / 100K
Incidence
6.8 / 100K/yr
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Preclinical(1)
| Drug | Company |
|---|---|
| sw-3431 | SpringWorks Therapeutics, Inc. (SWTX) |
Frequently asked questions
How many drugs are in development for Uterine Cancer?
BioSniper tracks 1 drug in development for Uterine Cancer across 1 company.
How many clinical trials target Uterine Cancer?
There are 3 clinical trials targeting Uterine Cancer tracked by BioSniper.
What is the prevalence of Uterine Cancer?
The estimated prevalence of Uterine Cancer is approximately 50.1 per 100,000 population.
Deep-dive into Uterine Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis